Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy effectively diagnoses and assesses hair loss severity in androgenetic alopecia and alopecia areata.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

COVID-19 might cause gray hair to regain color.

Platelet-rich plasma is a safe and effective treatment for hair loss, with fewer relapses than steroid treatment.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Trichoscopy, a hair loss evaluation technique, found that people with Androgenetic Alopecia have more thin hairs, yellow dots, and perifollicular discoloration than healthy individuals.

The Trichoscope is a valuable tool for diagnosing and monitoring hair loss conditions.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

A person's severe hair loss naturally reversed without treatment.

A person's severe hair loss naturally reversed without treatment.

The hairless mutant gene causes early hair loss and affects skin and thymus development in mice.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

Hair transplant surgery effectively treated a specific type of hair loss and is recommended as a primary treatment option.

Scalp Micropigmentation is an effective and safe option for hair restoration and camouflaging scalp scars.

Trichoscopy helps diagnose and assess the severity of two types of hair loss diseases, androgenetic alopecia and alopecia areata.

Hair can naturally regain color, and stress might influence greying and its reversal.

Intermediate hair follicles are a better model for studying hair growth and testing hair loss treatments.

The book is a detailed guide on hair growth issues and treatments, recommended for specialists and hospital libraries.

Ultraviolet rays damage hair, smoking may cause hair loss, and good nutrition is important for hair health, but genetics mainly decide hair thickness.

Hair greying is linked to reduced ATM protein in hair cells, which protects against stress and damage.

Outside factors like grooming, chemicals, and the environment can damage hair and cause disorders.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Hormones significantly influence hair growth, with conditions like hirsutism and patterned hair loss linked to hormone levels; more research is needed for full understanding.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Hair transplant techniques and scalp micropigmentation can effectively hide scars and hair loss after cranial surgery.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Radiation mainly affects keratinocyte stem cells, not melanocyte stem cells, causing hair to gray.

Excessive sun exposure damages hair, causing protein loss and color changes.